Ailomics Therapeutics, founded in 2022 and headquartered in Shanghai, China, is a therapeutics company focused on discovering novel targets.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Ailomics Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Ailomics Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.